If you are visually impaired or blind, you can visit the PDF version by Pressing CONTROL + ALT + 4
<br /> GASTROENTEROLOGY<br /> Tillotts supplement • emjreviews.com<br /> INSIDE<br /> How to Improve Your Success<br /> in Treating Mild and Moderate<br /> Inflammatory Bowel Disease<br /> HOW TO IMPROVE YOUR SUCCESS IN TREATING MILD<br /> AND MODERATE INFLAMMATORY BOWEL DISEASE<br /> Summary of presentations from the Tillotts Pharma-sponsored<br /> Satellite Symposium on Inflammatory Bowel Disease, held in<br /> Amsterdam, Netherlands, on 18th March 2016<br /> Chairperson<br /> Geert D’Haens1<br /> Speakers<br /> Ailsa Hart,2 Pieter Hindryckx3<br /> 1. Academic Medical Centre-IBD Unit, University of Amsterdam, Amsterdam, Netherlands<br /> 2. Director, IBD Unit, St Mark’s Hospital, London, UK<br /> 3. Research Gastroenterologist, Department of Gastroenterology,<br /> University Hospital of Ghent, Ghent, Belgium<br /> Disclosure: Within the last 3 yea<a title="EMJ Gastroenterol. 2016 Suppl 8 page 1" href="http://viewer.zmags.com/publication/e51d9eab?page=1"> GASTROENTEROLOGY Tillotts supplement • emjreviews</a> <a title="EMJ Gastroenterol. 2016 Suppl 8 page 2" href="http://viewer.zmags.com/publication/e51d9eab?page=2"> HOW TO IMPROVE YOUR SUCCESS IN TREATING MILD AN</a> <a title="EMJ Gastroenterol. 2016 Suppl 8 page 3" href="http://viewer.zmags.com/publication/e51d9eab?page=3"> Success Factors in the Treatment of Mild-to-Moder</a> <a title="EMJ Gastroenterol. 2016 Suppl 8 page 4" href="http://viewer.zmags.com/publication/e51d9eab?page=4"> escalating treatment.8 For patients with refracto</a> <a title="EMJ Gastroenterol. 2016 Suppl 8 page 5" href="http://viewer.zmags.com/publication/e51d9eab?page=5"> Predictors of non-adherence in chronic disea</a> <a title="EMJ Gastroenterol. 2016 Suppl 8 page 6" href="http://viewer.zmags.com/publication/e51d9eab?page=6"> including an American cohort study (N=248).2</a> <a title="EMJ Gastroenterol. 2016 Suppl 8 page 7" href="http://viewer.zmags.com/publication/e51d9eab?page=7"> on azathioprine as a maintenance therapy. In 2002</a> <a title="EMJ Gastroenterol. 2016 Suppl 8 page 8" href="http://viewer.zmags.com/publication/e51d9eab?page=8"> Educational interventions to improve patients</a> <a title="EMJ Gastroenterol. 2016 Suppl 8 page 9" href="http://viewer.zmags.com/publication/e51d9eab?page=9"> of inflammatory bowel diseases: new insights </a>